Takeda Chemical Industries, Ltd. v. Mylan Labs.

This document cites

• Federal Cases - Glaxo Group Ltd. v. Apotex, Inc.
• Federal Cases - Purepac Pharmaceutical Co. v. Thompson
• Federal Cases - Merck & Co. v. Teva Pharmaceuticals Usa
• Federal Cases - Knoll Pharmaceutical v. Teva Pharmaceuticals Usa
• Federal Cases - Graham v. John Deere Co.



See all quotations

• Federal Cases - Perseptive Biosystems Inc v. Pharmacia Biotech
• Federal Cases - Merck Kgaa v. Integra Lifesciences I, Ltd.
• Federal Cases - Merck & Co., Inc. v. Danbury Pharmacal, Inc.
• Federal Cases - Syntex (U.S.A.) LLC v. Apotex, Inc.
• Federal Cases - Ruiz v. A.B. Chance Company
• Federal Cases - Hoffmann-La Roche, Inc. v. Promega Corp.
• Federal Cases - Beckson Marine, Inc. v. Nfm, Inc.
• Federal Cases - In re Harnisch, Appeal No. 79-614.
• Federal Cases - Richardson-Vicks Inc. v. Upjohn Co.
• Federal Cases - Mova Pharmaceutical Corp. v. Shalala
• Federal Cases - Purdue Pharma L.P. v. Endo Pharmaceuticals Inc.
• Federal Cases - Akron Polymer Container Corp. v. Exxel Container, Inc.
• Federal Cases - Ferring B.V. v. Barr Laboratories, Inc.
• Federal Cases - Yamanouchi Pharmaceutical v. Danbury Pharmaceutical
• Federal Cases - Dayco Products, Inc. v. Total Containment, Inc.
• Federal Cases - Takeda Chemical Indust. v. Watson Pharmaceuticals
• Federal Cases - Ecolochem v. Southern California Edison Co.
• Federal Cases - Digital Control, Inc. v. Charles Mach. Works
• Federal Cases - Winner Int'l v. Ching-Rong Wang
• Federal Cases - Refac Intern., Ltd. v. Lotus Development Corp.
• US - Reference Stubs - Patent Trial and Appeal Board
• US - Reference Stubs - Inventions patentable
• US - Reference Stubs - Examination of application
• US - Reference Stubs - Specification
• US - Reference Stubs - Conditions for patentability; non-obvious subject matter
• US - Reference Stubs - Presumption of validity; defenses
• US - Reference Stubs - Duty to disclose information material to patentability
• US - Reference Stubs - New drugs
• US - Reference Stubs - Date of approval of a 505(b)(2) application or ANDA